M&A Deal Summary

Emcure Pharmaceuticals Acquires International Pharmaceutical Generics

On January 18, 2016, Emcure Pharmaceuticals acquired life science company International Pharmaceutical Generics

Acquisition Highlights
  • This is Emcure Pharmaceuticals’ 2nd transaction in the Life Science sector.
  • This is Emcure Pharmaceuticals’ 2nd transaction in Canada.
  • This is Emcure Pharmaceuticals’ 2nd transaction in Ontario.

M&A Deal Summary
Date 2016-01-18
Target International Pharmaceutical Generics
Sector Life Science
Buyer(s) Emcure Pharmaceuticals
Deal Type Add-on Acquisition

Target

International Pharmaceutical Generics

Ottawa, Ontario, Canada
International Pharmaceutical Generics Ltd. is a manufacturer and supplier of generic drugs and other pharmaceutical products.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Emcure Pharmaceuticals

Pune, India
Category Company
Founded 1981
Sector Life Science
DESCRIPTION

Emcure Pharmaceuticals is a mid-sized pharmaceutical business. The company's activities include research & development, manufacturing of APIs, branded formulations and biotech products, and marketing of these products in India and international markets. Emcure Pharmaceuticals was founded in 1981 and is based in Pune, India.

DEAL STATS #
Overall 2 of 2
Sector (Life Science) 2 of 2
Type (Add-on Acquisition) 1 of 1
State (Ontario) 2 of 2
Country (Canada) 2 of 2
Year (2016) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-01-18 Marcan Pharamaceuticals

Ottawa, Ontario, Canada

Marcan Pharamaceuticals, Inc. is a pharmaceutical company, manufactures and markets pharmaceutical products.

Buy -
Mergr

Product

Company

Legal